Background: Advanced maternal age (AMA) is the most frequent indication for amniocentesis in predicting balanced reciprocal translocations, and abnormal ultrasound findings are indications in predicting unbalanced reciprocal translocations; however, to date, no studies have focused on Robertsonian translocations. Methods: A retrospective review was conducted on 16,749 pregnant women who underwent midtrimester amniocentesis between January 1981 and December 2010. Robertsonian translocations were identified in 39 cases. Results: The percentage of Robertsonian translocations in all amniocentesis cases was 0.23% (39/16,749); 31 were balanced and eight were unbalanced. De novo abnormality occurred in 17 cases, or in 43.6% of all Robertsonian translocations. The two major indications for amniocentesis with a diagnosis of Robertsonian translocations were AMA (41.0%, n ¼ 16) and a parent with abnormal karyotypes (18.0%, n ¼ 7). The highest percentage of Robertsonian translocations was found in parents with abnormal karyotypes (2.8%, 7/252), but neither of the indications were clearly superior for detecting de novo Robertsonian translocations. Conclusion: Although AMA is an indication for amniocentesis in approximately two-fifths of cases with Robertsonian translocations, the indication of parent with abnormal karyotypes was more likely to lead to the detection of non-de novo Robertsonian translocations, suggesting that parents with abnormal karyotypes need careful prenatal consultation.
Introduction
Robertsonian translocations are structural chromosomal anomalies that result from the fusion of two acrocentric chromosomes. They are formed when the long arms of two acrocentric chromosomes are translocated, ultimately forming a single chromosome 1 ; they have an estimated incidence rate of 0.1% among a healthy population, and are therefore found in 1/500 healthy couples. 2 The clinical significance of Robertsonian translocations is the increased risk of spontaneous pregnancy wastage, infertility, and chromosomally unbalanced offspring. 3e6 The Robertsonian translocation is also referred to as a "centric fusion" type of translocation, and is a fusion of the entire long arms of two acrocentric chromosomes (chromosomes 13, 14, and 15 of the D group, and chromosomes 21 and 22 of the G group) after breakage at the centromeres. 3 During meiosis, these rearrangements form trivalents, the segregation of which may result in nullisomic or disomic gametes for one of the chromosomes involved in the rearrangement, and consequently, a zygote with trisomy or monosomy for one of the chromosomes involved. 7 In humans, an individual with what is called a "balanced" Robertsonian translocation shows only 45 chromosomes, with the translocation chromosome containing the two complete long arms of the two acrocentric chromosomes involved. 1 The short arms of the two translocated chromosomes are lost. 1 The most common Robertsonian translocation is between chromosomes 13 and 14. The translocation between the D and G groups is responsible for approximately 75% of all Robertsonian translocations, and the potential live-born chromosomally unbalanced outcome of this is translocation trisomy 13; there is also potential for uniparental disomy for chromosome 14 following trisomy rescue. 8 The second most common Robertsonian translocation is the translocation between the D and G groups (14 and 21) , and the potential live-born unbalanced outcome of this Robertsonian translocation between the D and G groups is translocation trisomy 21, resulting in Down syndrome. 7 Although most of the short arms of the human acrocentric chromosomes are lost after translocation, balanced Robertsonian translocation carriers are phenotypically normal, 1 because the short arms mainly contain tandemly repeated satellite DNA sequences and the ribosomal RNA genes, which are present in all five pairs of acrocentric chromosomes. 3 To date, only a few studies have addressed the indications for amniocentesis to detect Robertsonian translocations, and fewer studies have discussed the detection rate of the indications for Robertsonian translocations. 8, 9 In addition, even fewer studies have discussed de novo Robertsonian translocations, because the majority of studies have focused on Robertsonian translocation carriers. 10 A recent large series showed that advanced maternal age (AMA) was the most frequent indication for amniocentesis in predicting balanced reciprocal translocations, and abnormal ultrasound findings were indications in predicting unbalanced reciprocal translocations, 11 but so far no studies have focused on Robertsonian translocations.
However, for detecting Robertsonian translocations, abnormal biochemical markers in maternal serum along with abnormal ultrasound findings might be most important, because these two were not only the most common indications for amniocentesis but also had the highest detection rate for chromosomal aberrations, including Robertsonian translocations. 9 Although the previously described data are available, we would like to share our data, based on a 30-year experience in a single tertiary center, 12, 13 and use them to study the indications and detection rates of Robertsonian translocations in cases undergoing amniocentesis, which would be of great value to couples who need further genetic counseling.
Methods
Data were obtained from amniocentesis records of the cytogenetic laboratory at Taipei Veterans General Hospital, a tertiary medical center, between 1981 and 2010. 12, 13 The detailed information on the indications for a prenatal diagnosis of chromosomal abnormality with cytogenetic analysis has been described elsewhere, 14e17 which includes (1) AMA (i.e., if the mother will be 34 years at the expected date of confinement), (2) abnormal chorionic villus sampling results, (3) abnormal biochemical markers in the maternal serum, such as screening maternal blood for Down syndrome (1/270), (4) abnormal ultrasound findings, (5) intrauterine fetal death, (6) family history of chromosomal abnormalities, (7) parent with abnormal karyotype, (8) history of abnormal offspring at birth, (9) radiation or medication exposure during pregnancy, and (10) other nonspecific indications, such as anxiety, consanguineous marriage, and so on.
The frequencies of Robertsonian translocations and the de novo-type of Robertsonian translocations in various indications were estimated.
Results
In this study, a total of 16,749 cases of amniocentesis were analyzed, of which 39 were identified as Robertsonian translocations. The highest proportion of Robertsonian translocations was identified in cases with the indications of AMA (41%, 16/39), followed by parental abnormal karyotypes (18%, 7/39), other nonspecific indications (12.8%, 5/39), detection of abnormal biochemical markers in maternal serum (10.3%, 4/39), and abnormal ultrasound findings (10.3%, 4/39) ( Table 1) .
There were 30 and nine balanced and unbalanced Robertsonian translocations, respectively (Table 1) . Consistent with the above data, AMA and parental abnormal karyotypes were still the major indications for amniocentesis to detect Robertsonian translocations, contributing to 46.7% (14/30) and 20% (6/30), respectively, of the cases of balanced Robertsonian translocations, while other nonspecific indications were involved in 10.7% of the cases. However, for cases of unbalanced Robertsonian translocations, none of the indications were significant, i.e., AMA, abnormal biochemical markers in maternal serum, abnormal ultrasound findings, and other nonspecific indications contributed equally to the detection of unbalanced Robertsonian translocations (22.2% in all). By contrast, parental abnormal karyotypes were not so obvious in cases of unbalanced Robertsonian translocations (Table 1) .
In this study, AMA was a main indication for amniocentesis in the detection of de novo balanced Robertsonian translocations (58.3%, 7/12), and abnormal ultrasound findings were a major indication in the detection of de novo unbalanced Robertsonian translocations (40%, 2/5) ( Table 2 ). The frequencies of de novo Robertsonian translocations for every individual indication, and that abnormal ultrasound findings and family history had the highest frequency (Table 2) suggest that fetuses with structural abnormalities that are detected during the prenatal ultrasound examination should be carefully evaluated, because these fetuses might have a higher risk of the underlying chromosomal abnormality.
The overall percentage of Robertsonian translocations in all amniocentesis cases was 0.23% (39/16,749) ( Table 3) . While evaluating the frequency of Robertsonian translocations for all indications, a parent with abnormal karyotype was found to have the highest percentage (2.78%, 7/252) ( Table 3) . None of the other indications had a detection rate above 1%. The frequency of Robertsonian translocations in the AMA group was low (0.15%), and that of abnormal biochemical markers in maternal serum was also low (0.19%). Both were below the average frequency for all cases with other indications for amniocentesis. For detecting de novo Robertsonian translocations with different indications for amniocentesis, both abnormal ultrasound findings and family history had the highest rates (0.41% and 0.55%, respectively; Table 3 ). Consistent with the low frequency of Robertsonian translocation detection with AMA and abnormal biochemical markers in maternal serum groups, the frequency of de novo Robertsonian translocations was also low in both groups ( Table 3) .
The most common de novo Robertsonian translocation types involved chromosomes 13 and 14, accounting for 41.2% of all de novo Robertsonian translocation types ( Table 4 ). The second most common type involved chromosome 21. In fact, all de novo Robertsonian translocations involved chromosomes 13, 14, and 21.
Discussion
Consistent with previous domestic reports, 8 AMA was a main indication for amniocentesis, and there is no doubt that it also accounted for a large number of Robertsonian translocation cases (n ¼ 14), although the detection rate was only 0.15%, which was significantly lower than the average of all indications. In fact, AMA is always a main indication for amniocentesis, but the detection rate for abnormality is low. 8 Abnormal biochemical markers in the maternal serum was another important indication for amniocentesis, 18 accounting for 10% of all cases undergoing amniocentesis. Although the indication rate was similar to that of the detection of all Robertsonian translocations, the detection rate was below the average of all indications. By contrast, parents with abnormal karyotypes might not be such an obvious indication for amniocentesis, but this indication accounted for the detection of 18% of all Robertsonian translocations and resulted in a very high frequency of Robertsonian translocations (11-fold increased risk, 2.78%/ 0.23%). The role of parent with abnormal karyotypes was more significant and was confirmed in many studies, 19 if we consider it as an indication for detecting non-de novo Robertsonian translocations.
The other significant indication in the current study was abnormal ultrasound findings, which accounted for only 2.9% of all indications for amniocentesis, but 10.3% of all Robertsonian translocation cases with a fourfold increased risk (0.41% vs. 0.10% and 0.83% vs. 0.23%, respectively). This close correlation between abnormal ultrasound findings and Robertsonian translocations is significant not only for the role of abnormal ultrasound findings as an indication to detect Robertsonian translocations, 19 but also for the role of the detection of Robertsonian translocations as a need for highresolution prenatal ultrasound examinations. In a study of a northern Taiwan population, the frequency of all Robertsonian translocations and de novo Robertsonian translocations in 12,468 amniocentesis specimens was 0.085% and 0.016%, respectively. 17 However, the major congenital anomaly rates of inherited and de novo chromosome rearrangements were 1.96% and 6.66%, respectively, which were significantly higher than the 1.4% congenital anomaly rate in the general population, 17 suggesting that the de novo chromosomal rearrangement contributes to an especially high risk of congenital abnormalities, although we cannot identify the related mapping of genes and discover the function of the individual genes. 20 In this situation, the use of obstetric ultrasound may be an opportunity to provide additional findings that may help parents make decisions regarding their pregnancy. 14, 21 In the study, we reported the frequency of de novo Robertsonian translocation types. Consistent with the above findings, the most common de novo Robertsonian translocation types in this study also involved chromosomes 13 and 14 [rob(13q14q)], and accounted for 41.2% of all de novo Robertsonian translocation types. However, the second most common form was rob(21q21q), which accounted for 29.4% of all de novo Robertsonian translocations.
In conclusion, our study showed that only AMA was a major indication for amniocentesis to diagnose Robertsonian translocations; however, a parent with abnormal karyotype and abnormal ultrasound findings may be more important as indications for amniocentesis to detect Robertsonian translocations, because parent with abnormal karyotype showed the highest rate of detection of Robertsonian translocations, and abnormal ultrasound showed the highest rate of detection of de novo Robertsonian translocations. Both conditions should be carefully monitored and further genetic testing should be conducted. 
